Rusnano and Renova hold respective shares in Xevel of 51% and 49% and will contribute as much to the investment.
Renova on its website claims to be Russia's "leading private business group," which is made of asset companies and portfolio investment funds having stakes and managing assets in metals mining, oil, machine building, mining, nanotechnologies and other fields, both in Russian and abroad.
Rusnano was established by the Russian government to boost commercialized developments in the nanotechnology sector, according to the Rusnano website.
Xevel was founded by the two in 2009 to take on production of narrow band gap polymers-based photovoltaic cells.
If all goes accordingly, Xevel is set to launch several solar plants over 600 MW by 2020.
In addition, the companies have agreed on implementation of a set of measures aimed at furthering development of high-tech solar energy projects.
Specifically, Renova is obligated to provide Xevel a loan of $155 million for refinancing some of its loss-generating activities in which Rusnano holds a stake.
This content is protected by copyright and may not be reused. If you want to cooperate with us and would like to reuse some of our content, please contact: editors@pv-magazine.com.
By submitting this form you agree to pv magazine using your data for the purposes of publishing your comment.
Your personal data will only be disclosed or otherwise transmitted to third parties for the purposes of spam filtering or if this is necessary for technical maintenance of the website. Any other transfer to third parties will not take place unless this is justified on the basis of applicable data protection regulations or if pv magazine is legally obliged to do so.
You may revoke this consent at any time with effect for the future, in which case your personal data will be deleted immediately. Otherwise, your data will be deleted if pv magazine has processed your request or the purpose of data storage is fulfilled.
Further information on data privacy can be found in our Data Protection Policy.